Epinal unveils breath biosensor for narcotics, biomarkers

Epinal, Inc. said it has emerged from stealth with a Semiconductor Electrochemical Biosensor designed for breath-based detection of narcotics and disease biomarkers within minutes.

The Irvine, California, company said the sensor combines semiconductor engineering, electrochemical sensing, protein engineering and artificial intelligence. It said the technology is intended for use in low-cost, disposable breathalyzer cartridges for future screening and diagnostic devices.

Epinal said potential customers include breathalyzer manufacturers, healthcare companies, medtech and biotech device makers, mobile computer and clinical smartphone companies, and mobile phone manufacturers.

Founder, Executive Chairman and Chief Strategy Officer Mike Neshat said Epinal is in the final stages of refining the sensor for production in 2028. Mark Wong is the company's co-founder and chief executive officer, and Dwight Dunagan is chief operating officer.